A detailed history of Nicollet Investment Management, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Nicollet Investment Management, Inc. holds 5,833 shares of UTHR stock, worth $2.1 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
5,833
Previous 5,772 1.06%
Holding current value
$2.1 Million
Previous $1.84 Million 13.65%
% of portfolio
0.72%
Previous 0.69%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$311.04 - $363.55 $18,973 - $22,176
61 Added 1.06%
5,833 $2.09 Million
Q2 2024

Aug 07, 2024

SELL
$228.26 - $319.04 $34,467 - $48,175
-151 Reduced 2.55%
5,772 $1.84 Million
Q1 2024

May 02, 2024

BUY
$210.76 - $249.51 $5,901 - $6,986
28 Added 0.47%
5,923 $1.36 Million
Q4 2023

Feb 12, 2024

BUY
$214.88 - $256.94 $22,992 - $27,492
107 Added 1.85%
5,895 $1.3 Million
Q3 2023

Nov 09, 2023

BUY
$211.82 - $248.24 $24,359 - $28,547
115 Added 2.03%
5,788 $1.31 Million
Q2 2023

Aug 08, 2023

BUY
$205.19 - $232.99 $27,290 - $30,987
133 Added 2.4%
5,673 $1.25 Million
Q1 2023

May 09, 2023

SELL
$212.99 - $276.17 $53,247 - $69,042
-250 Reduced 4.32%
5,540 $1.24 Million
Q4 2022

Feb 06, 2023

SELL
$205.95 - $280.43 $9,061 - $12,338
-44 Reduced 0.75%
5,790 $1.61 Million
Q3 2022

Nov 08, 2022

BUY
$203.3 - $244.17 $37,610 - $45,171
185 Added 3.27%
5,834 $1.22 Million
Q2 2022

Aug 11, 2022

BUY
$174.81 - $241.14 $12,061 - $16,638
69 Added 1.24%
5,649 $1.33 Million
Q1 2022

May 04, 2022

SELL
$166.16 - $213.96 $40,044 - $51,564
-241 Reduced 4.14%
5,580 $1 Million
Q4 2021

Feb 09, 2022

SELL
$184.32 - $216.08 $22,855 - $26,793
-124 Reduced 2.09%
5,821 $1.26 Million
Q3 2021

Nov 05, 2021

BUY
$179.86 - $214.88 $539 - $644
3 Added 0.05%
5,945 $1.1 Million
Q2 2021

Jul 28, 2021

SELL
$170.47 - $211.93 $3,920 - $4,874
-23 Reduced 0.39%
5,942 $1.07 Million
Q1 2021

May 10, 2021

SELL
$153.94 - $174.85 $3,386 - $3,846
-22 Reduced 0.37%
5,965 $998,000
Q4 2020

Feb 09, 2021

BUY
$101.87 - $151.79 $21,290 - $31,724
209 Added 3.62%
5,987 $909,000
Q3 2020

Nov 10, 2020

SELL
$99.9 - $121.13 $15,184 - $18,411
-152 Reduced 2.56%
5,778 $584,000
Q2 2020

Aug 04, 2020

BUY
$92.74 - $125.82 $4,173 - $5,661
45 Added 0.76%
5,930 $718,000
Q1 2020

May 04, 2020

BUY
$79.39 - $115.35 $4,366 - $6,344
55 Added 0.94%
5,885 $558,000
Q4 2019

Feb 07, 2020

SELL
$78.31 - $95.34 $16,836 - $20,498
-215 Reduced 3.56%
5,830 $514,000
Q3 2019

Nov 12, 2019

BUY
$74.85 - $85.99 $4,116 - $4,729
55 Added 0.92%
6,045 $482,000
Q2 2019

Aug 09, 2019

SELL
$76.06 - $120.81 $2,281 - $3,624
-30 Reduced 0.5%
5,990 $468,000
Q4 2018

Feb 11, 2019

SELL
$101.4 - $128.73 $5,070 - $6,436
-50 Reduced 0.82%
6,020 $656,000
Q3 2018

Nov 13, 2018

BUY
$113.81 - $129.46 $22,192 - $25,244
195 Added 3.32%
6,070 $776,000
Q2 2018

Aug 09, 2018

BUY
$101.14 - $118.31 $7,585 - $8,873
75 Added 1.29%
5,875 $665,000
Q4 2017

Feb 06, 2018

BUY
$118.58 - $151.28 $687,764 - $877,424
5,800
5,800 $858,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Nicollet Investment Management, Inc. Portfolio

Follow Nicollet Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicollet Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nicollet Investment Management, Inc. with notifications on news.